01
Company
Company
Vision and Values
Citizenship
Leadership Team
Board of Directors
Our Locations
02
Products & Services
Products
R&D
Generics
Export Oncology
Facilities
Contract Research
03
Investors
Investors
Corporate Governance
Monthly Sales
Quarterly Results
Shareholders Services
Financial Calendar
04
Newsroom
Contact Us
Language
Languages
English
Chinese
Alvogen Korea
Company
Products & Services
Investors
Newsroom
Company
Vision and Values
Citizenship
Leadership Team
Board of Directors
Our Locations
Products
R&D
Generics
Export Oncology
Facilities
Contract Research
Investors
Corporate Governance
Monthly Sales
Quarterly Results
Shareholders Services
Financial Calendar
Skip Navigation
Investors
Financial Calendar
Previous events
15 May 2023
Lotus Reports Strong First-Quarter 2023 Results with EPS of NT$4.58
12 April 2023
Monthly Sales - March 2023
13 March 2023
Quarterly Results-Fourth Quarter 2022
10 March 2023
Monthly Sales - February 2023
10 February 2023
Monthly Sales - January 2023
10 January 2023
Monthly Sales - December 2022
09 December 2022
Monthly Sales - November 2022
10 November 2022
Monthly Sales - October 2022
10 November 2022
Quarterly Results-Third Quarter 2022
11 October 2022
Monthly Sales - September 2022
09 September 2022
Monthly Sales - August 2022
12 August 2022
Quarterly Results-Second Quarter 2022
10 August 2022
Monthly Sales - July 2022
08 July 2022
Monthly Sales - June 2022
10 June 2022
Monthly Sales - May 2022
13 May 2022
Quarterly Results-First Quarter 2022
10 May 2022
Monthly Sales - April 2022
11 April 2022
Monthly Sales - March 2022
22 March 2022
FY2021 Results
10 March 2022
Monthly Sales - February 2022